Kratom alkaloids and O-desmethyltramadol in urine of a "Krypton" herbal mixture consumer

Forensic Science International

Volumn 208, Issue 1-3, 2011, Pages 47-52

  Arndt, Torsten ^a   Claussen, Ulrich ^b   Güssregen, Brunhilde ^a   Schröfel, Stefanie ^a   Stürzer, Birgit ^b   Werle, Annika ^a   Wolf, Gerald ^b  

^a Bioscientia Center for Human Genetics   (Germany)

^b Therapeutische Einrichtung Auf der Lenzwiese   (Germany)

Author keywords

Kratom; Krypton; LC MS MS; Mitragynine; O desmethyltramadol; Speciociliatine

Indexed keywords

ALKALOID; AMPHETAMINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZOYLECGONINE; BUPRENORPHINE; COCAINE; DIAMORPHINE; ETHYL GLUCURONIDE; HERBACEOUS AGENT; KRATOM ALKALOID; KRYPTON HERBAL MIXTURE; METHADONE; MITRACILIATINE; MITRAGYNINE; O NORTRAMADOL; OPIATE; OXYCODONE; PAYNANTHEINE; SPECIOCILIATINE; SPECIOGYNINE; TRAMADOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE REPORT; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CLONED ENZYME DONOR IMMUNOASSAY; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MITRAGYNA; MITRAGYNA SPECIOSA; OPIATE ADDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCREENING; TEST STRIP; URINALYSIS;

EID: 79955464113     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.10.025     Document Type: Article

References (15)

1. Takayama H. Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa. Chem. Pharm. Bull. 2004, 52:916-928.
2. Macko E., Weisbach J.A., Douglas B. Some observations on the pharmacology of mytragynine. Arch. Int. Pharmacodyn. 1972, 198:145-161.
3. Philipp A.A., Wissenbach D.K., Zoerntlein S.W., Klein O.N., Kanogsunthornrat J., Maurer H.H. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry. J. Mass Spectrom. 2009, 44:1249-1261.
4. Maurer H.H. Chemistry, pharmacology, and metabolism of emerging drugs of abuse. Ther. Drug Monit. 2010, 32:544-549.
5. EMCDDA, Thematic papers, Understanding the "Spice" Phenomenon, 2009, (last cited September 29, 2010). http://www.emcdda.europa.eu/.
6. nal von minden, Drug Screen Tauchtest (single & multi) Package insert 060608, 2008.
7. ThermoFisher Scientific Microgenics CEDIA Test Instructions 2009, CD-ROM.
8. C. Pingsuthiwong, A. Krispitakneong, A. Intrarachai, N. Matra, Analysis of Mitragyna speciosa (kratom) alkaloids in human urine as a marker of chronic kratom abuse: preliminary results, 2007, (last cited September 29, 2010). http://www.icadts2007.org/print/poster127_mitragynaspalkaloids.pdf.
9. Philipp A.A., Wissenbach D.K., Weber A.A., Zapp J., Zoerntlein S.W., Kanogsunthornrat J., Zweipfennig P.G.M., Maurer H.H. Monitoring of Kratom alkaloids and its metabolites in urine using LC-Linear Ion Trap-MSn and GC-MS. Toxichem. Krimtech. 2010, 77:180.
10. Lu S., Tran B.N., Nelsen J.L., Aldous K.M. Quantitative analysis of mitragynine in human urine by high performance liquid chromatography-tandem mass spectrometry. J. Chromatogr. B 2009, 877:2499-2505.
11. Philipp A.A., Wissenbach D.K., Weber A.A., Zapp J., Zoerntlein S.W., Kanogsunthornrat J., Maurer H.H. Use of liquid chromatography coupled to low- and high resolution linear ion trap mass spectrometry for studying the metabolism of paynantheine, an alkaloid of the herbal drug Kratom in rat and human urine. Anal. Bioanal. Chem. 2010, 396:2379-2391.
12. Baselt R.C. Disposition of Toxic Drugs and Chemicals in Man 2008, Biomedical Publications, Foster City, CA. eighth ed.
13. Dresen S., Ferreiros N., Pütz M., Westphal F., Zimmermann R., Auwärter V. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J. Mass Spectrom. 2010, 45:1186-1194.
14. ThermoFisher Scientific Microgenics, Drugs of Abuse CEDIA® Cross-Reactivity Performance Guide (Version 2008) incl. Cross-Reactivity Supplementary Data CEDIA® (Version April 2008).
15. Arndt T., Claussen U., Güssregen B., Schröfel S., Stürzer B., Werle A., Wolf G. "Krypton" -Konsum als Ursache eines positiven O-Desmethytramadol-Nachweises im Urin einer Opiatabhängigen in der Entwöhnungstherapie. Toxichem. Krimtech. 2010, 77:23-28.